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Background: Pulmonary vascular resistance (PVR) is an important hemodynamic measurement used in the management of patients with heart 
failure and pulmonary hypertension. The mechanisms of PVR increase are incompletely understood, although pulmonary vasculature remodeling 
implicated. We evaluated the relationship between PVR and circulating Matrix metalloproteinase (MMP)-2/tissue inhibitors of metalloproteinase 
(TIMP)-2 levels, which are matrix-degrading enzymes that influence vascular and ventricular remodeling, in patients with chronic heart failure (CHF).
methods:We enrolled 173 HF patients who were undergoing invasive hemodynamic study. PVR was then calculated as (mPAP - PCWP)/cardiac 
output multiplied by 80. Circulating levels of MMP-2 and TIMP-2 were determined by ELISA. Atrial natriuretic peptide (ANP) and Brain natriuretic 
peptide (BNP) values were also assessed. All patients were treated with ordinary regimen.
results:  PVR had significant positive correlations with serum MMP-2 levels and MMP-2/TIMP-2 ratio (r=0.176, P<0.05 and r=0.441, P<0.01). PVR 
did not change according to the NYHA functional class. Both levels of ANP and BNP had significant positive correlations with PVR (r=0.174, P<0.05 
and r=0.186, P<0.05, respectively). 
conclusions:  PVR is correlated with MMP-2 and MMP-2/TIMP-2 ratio values in CHF patients. This result suggests the disparity between MMP-2 
and TIMP-2 contribute to the progression of pulmonary vasculature remodeling in patients with CHF.
 
